Supporting this notion, a recent study in patients with anxiety disorders provided initial evidence that pre- to post-treatment changes in FKBP5 methylation were strongly associated with treatment outcome at six-month follow-up but not at post-treatment (Roberts et al. 2019). This evidence concerns the gene FKBP5 and anxiety disorder.